Shares of Eli Lilly & Co. LLY rallied 3.26% to $864.90 Monday, on what proved to be an all-around great trading session for ...

Novo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

In contrast, Eli Lilly (NYSE: LLY) and Hims & Hers Health (NYSE: HIMS) both jumped on today's news. They rose 2.7% and 7%, ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

We recently published a list of Was Jim Cramer Right About These 23 Stocks? In this article, we are going to take a look at ...

Augustine Therapeutics, a Belgian biotech developing therapies for neuromuscular, neurodegenerative and cardio-metabolic ...

Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese pharmaceutical company the United Bio-Technology (Hengqin) Co., as it looks to ...

Janus Henderson is a global investment management company that provides diverse mutual funds in equities, fixed-income and multi-asset strategies. Janus Henderson was created by the 2017 merger ...

Augustine Therapeutics has raised €78 million ($85 million) in first-round funding for a pipeline headed by a candidate for ...

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the ...

Leuven, Belgium-based Augustine Therapeutics NV, a biotechnology company, has secured €77.7M in an oversubscribed Series A funding round co-led by Novo ...